Dan Shingo | Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
スポンサーリンク
概要
- DAN Shingoの詳細を見る
- 同名の論文著者
- Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researcの論文著者
関連著者
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer
-
Dan Shingo
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
YAMORI Takao
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Dan Shingo
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yoshida Yoko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamazaki Kanami
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yoshida Yoko
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
Yamazaki Kanami
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Okamura Mutsumi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yoshimi Hisashi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yoshida Yoko
Division Of Diabetes And Metabolism The Institute For Adult Diseases Asahi Life Foundation
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
NAKATSU Noriyuki
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
OKAYASU Ryuichi
Heavy-ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Instit
-
Anzai Kazunori
Heavy-ion Radiobiology Research Group National Institute Of Radiological Sciences
-
Nakamura Tomoki
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Sadahiro Soutaro
Second Department of Surgery, Tokai University School of Medicine
-
Makuuchi Hiroyasu
Second Department of Surgery, Tokai University School of Medicine
-
SHIRAKAWA Mieko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
MUKAI Yumiko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
KAWAGUCHI Tokuichi
Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research
-
MATSUURA Masaaki
Bioinformatics Group, Genome Center, Japanese Foundation for Cancer Research
-
NAKAMURA Hiroyuki
Division of Cardiology, Sakaide Municipal Hospital
-
UNNO Michiaki
Division of Gastroenterological Surgery, Endocrinology and Vascular Medicine, Tohoku University Grad
-
Unno Michiaki
Department Of Gastroenterological Surgery Tohoku University Graduate School Of Medicine
-
Unno Michiaki
Division Of Biological Regulation And Oncology Department Of Surgery Tohoku University Graduate Scho
-
Unno Michiaki
Division Of Hepato-biliary-pancreatic Surgery Tohoku University Graduate School Of Medicine
-
Unno Michiaki
Division Of Gastroenterological Surgery Department Of Surgery Tohoku University School Of Medicine
-
中津 則之
東大院農
-
Irimura Tatsuro
Laboratory Of Cancer Biology And Molecular Immunology ; Graduate School Of Pharmaceutical Sciences T
-
Shiina Isamu
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science
-
Nakamura Yusuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Mukai Y
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Shiina Isamu
Department Of Applied Chemistry Faculty Of Science Science University Of Tokyo
-
AKASHI Tetsuyuki
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamazaki Kanami
Div. Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Res.
-
Yamori Takao
Div. Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Res.
-
Nakamura Yusuke
Laboratory For Molecular Medicine Human Genome Center The Institute Of Medical Science University Of
-
Nakatsu Noriyuki
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Shirakawa Mieko
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Kawaguchi Tokuichi
Department Of Cell Biology Japanese Foundation For Cancer Research Cancer Institute
-
Yamori Takao
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yaguchi Shin-ichi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Akashi Tetsuyuki
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Sekine Suzuki
Heavy-ion Radiobiology Research Group National Institute Of Radiological Sciences
-
Enami Jumpei
Central Research Laboratory Zenyaku Kogyo Co.
-
UENO Megumi
Heavy-ion Radiobiology Research Group, National Institute of Radiological Sciences
-
OKAMURA Mutsumi
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
YOSHIMI Hisashi
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Dan Shingo
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Dan Shingo
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yaguchi Shin-ichi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Matsuura Masaaki
Bioinformatics Group Genome Center Japanese Foundation For Cancer Research
-
Okayasu Ryuichi
Heavy-ion Radiobiology Res. Group Res. Center For Charged Particle Therapy National Inst. Of Radiolo
-
Nakamura Yusuke
Laboratory For Genotyping Riken Snp Research Center C/o Riken Yokohama Institute
-
Yamori Takao
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Okayasu Ryuichi
Heavy-ion Radiobiology Research Group National Institute Of Radiological Sciences
-
Nakamura Hiroyuki
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Ueno Megumi
Heavy-ion Radiobiology Research Group National Institute Of Radiological Sciences
-
Yamazaki Kanami
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Nakamura Hiroyuki
Division Of Cardiology Sakaide Municipal Hospital
-
Isoyama Sho
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
OKAYASU Ryuichi
Heavy-ion Radiobiology Research Group, National Institute of Radiological Sciences
-
YOSHIDA Yoko
Sanuma Municipal General Hospital
-
Nakatsu Noriyuki
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Yoshida Yoko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Guo Wen-zhi
Division of Molecular pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Wang Yanwen
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science
-
Umeda Eri
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science
-
Seki Mariko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
著作論文
- Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo
- Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
- Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines